| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 2.618 | 3.201 | 3.441 | 2.715 | 5.144 | 5.294 | 6.927 | 10.796 | 10.678 |
| Total Income - EUR | 0 | 2.618 | 3.201 | 3.441 | 2.715 | 5.370 | 5.294 | 6.927 | 10.796 | 10.678 |
| Total Expenses - EUR | 467 | 5.724 | 7.394 | 9.010 | 10.601 | 6.331 | 3.132 | 4.078 | 8.509 | 12.910 |
| Gross Profit/Loss - EUR | -467 | -3.106 | -4.193 | -5.569 | -7.886 | -960 | 2.163 | 2.849 | 2.287 | -2.232 |
| Net Profit/Loss - EUR | -467 | -3.185 | -4.261 | -5.604 | -7.913 | -1.014 | 2.005 | 2.699 | 2.179 | -2.232 |
| Employees | 0 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Napoca Derma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 151 | 95 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 0 | 0 | 1 | 5 | 31 | 409 | 3.442 | 4 | 869 | 923 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 205 | 0 | 0 | 44 |
| Receivables | 0 | 0 | 0 | 0 | 30 | 393 | 50 | 0 | 0 | 2 |
| Cash | 0 | 0 | 1 | 5 | 1 | 16 | 3.186 | 4 | 869 | 878 |
| Shareholders Funds | -422 | -3.602 | -7.802 | -13.241 | -20.898 | -21.516 | -19.034 | -16.394 | -14.166 | -16.319 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 572 | 3.697 | 7.843 | 13.246 | 20.929 | 21.925 | 22.476 | 16.398 | 15.035 | 17.243 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Napoca Derma Srl